Michael Metzger, President & CEO, Director at Tobira Therapeutics, holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA), holds 0.00 shares in CTI BioPharma (Ticker: CTIC), holds 17.66K shares in Syndax Pharmaceuticals (Ticker: SNDX). Most recently, Michael Metzger ― shares of Tobira Therapeutics on ― for an estimated value of ―.